Momeny et al. showed the potential anti-cancer activity of silibinin to inhibit the proliferative and invasive characteristics of the epithelial ovarian cancer cells that show an autocrine heregulin/human epidermal growth factor receptor 3 (HRG/HER3) pathway [32]. This evidence concerns the gene NRG1 and cancer.